Home/Filings/4/0001225208-25-002710
4//SEC Filing

DAMICO JENNIFER B. 4

Accession 0001225208-25-002710

CIK 0000078003other

Filed

Mar 2, 7:00 PM ET

Accepted

Mar 3, 5:39 PM ET

Size

10.1 KB

Accession

0001225208-25-002710

Insider Transaction Report

Form 4
Period: 2025-02-27
DAMICO JENNIFER B.
SVP & Controller
Transactions
  • Exercise/Conversion

    Common Stock

    2025-02-27$31.31/sh+22,416$701,84531,063 total
  • Tax Payment

    Common Stock

    2025-02-27$26.10/sh553$14,43330,510 total
  • Exercise/Conversion

    Stock Appreciation Rights

    2025-02-2722,4160 total
    Exercise: $31.31From: 2025-02-27Exp: 2025-02-27Common Stock (22,416 underlying)
  • Tax Payment

    Common Stock

    2025-02-27$26.06/sh20,994$547,1049,516 total
Footnotes (4)
  • [F1]The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
  • [F2]The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
  • [F3]The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
  • [F4]Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.

Documents

1 file

Issuer

PFIZER INC

CIK 0000078003

Entity typeother

Related Parties

1
  • filerCIK 0001805617

Filing Metadata

Form type
4
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 5:39 PM ET
Size
10.1 KB